Group 1 - Sichuan Chengyu's wholly-owned subsidiary plans to acquire 85% equity of Hubei Jingyi Company for 2.409 billion yuan, enhancing the company's control over highway projects [1] - Huadian Technology signed contracts worth approximately 815 million yuan with Huadian Technology Group for a wind power hydrogen production project [2] - Dongfang Cable and its subsidiary won projects totaling approximately 3.125 billion yuan, accounting for 34.37% of the company's audited revenue for 2024 [3] Group 2 - Heng Rui Medicine received approval for clinical trials of SHR-2906 injection, a self-developed biopharmaceutical aimed at weight control and metabolic regulation [4] - Qingdao Port plans to invest approximately 15.7 billion yuan in two terminal projects [5] - Jingu Co. received a notification to supply low-carbon wheels for two export models to a major domestic car manufacturer, with production expected in 2026 [6] Group 3 - ST Xingguang won a procurement project worth approximately 22.955 million yuan, accounting for 11.96% of the company's revenue for 2024 [7] - Xinbo Co. plans to jointly invest in an alloy materials research institute with partners, focusing on high-performance materials for various industries [8] - Tianqi Lithium's third-phase lithium concentrate expansion project has been completed and is undergoing trial production, with a total capacity of 2.14 million tons per year [9] Group 4 - Changfei Fiber reported that new fiber optic products related to data centers represent a small proportion of total demand [10] - Dongfang Bio's subsidiaries obtained multiple medical device registration certificates, including various testing kits [11] - Xiugang Co. plans to use up to 500 million yuan of idle fundraising for cash management in safe, liquid investment products [12] Group 5 - Jifeng Co. received a project designation for passenger car seat assemblies from a European luxury brand, with a total lifecycle value of approximately 9.8 billion yuan [13] - CanSino initiated Phase I clinical trials for a combined vaccine, completing the first subject enrollment [14] - Dayu Water-saving's subsidiary pre-won a drainage project worth 140 million yuan and another project worth 1 billion yuan [15] Group 6 - Yutong Pharmaceutical's subsidiary received clinical trial approval for YKYY032 injection for treating hyperlipoproteinemia [17] - Diweier announced the departure of a core technical personnel, impacting its technical leadership [18] - Weilang Co.'s controlling shareholder received regulatory measures from the Shandong Securities Regulatory Bureau for failing to fulfill a commitment [19] Group 7 - Xiehe Electronics invested 5 million yuan in a private equity fund focusing on hard technology sectors [20] - Phoenix Optical received a government subsidy of 4.7053 million yuan, representing 35% of its projected net profit for 2024 [21] - China State Construction reported a 0.9% year-on-year increase in new contracts signed in the first 11 months of 2025, totaling 4.0408 trillion yuan [22] Group 8 - Nanguang Energy's pumped storage power station units 1 and 2 have entered trial operation, with units 3 and 4 expected to follow by year-end [23] - Jindalai plans to invest 280 million yuan to acquire a 34% stake in Yunnan Jici Medical Technology [24] - Geer Software terminated its planned acquisition of a majority stake in Weipin Zhiyuan due to failure to reach agreement on key terms [25] Group 9 - Ningbo Fubang completed the absorption merger of its wholly-owned subsidiary, inheriting all assets and liabilities [26] - Zhongyuan Neipei signed a strategic cooperation framework agreement with Ningbo Puzhi Company for humanoid robot-related business [28] - Gongyuan Co. announced a business integration and relocation of its production lines in the East China region [29] Group 10 - Chlor-alkali Chemical's subsidiary plans to invest 2.975 billion yuan in a comprehensive utilization project for waste salt [30] - Kain Technology announced the departure of a core technical personnel, impacting its research capabilities [31] - ST Renfu received approval for clinical trials of a new drug for idiopathic pulmonary fibrosis [32] Group 11 - Sanbo Brain Science's established brain science fund has completed registration with the Asset Management Association of China [33] - Tongyou Technology plans to apply for a 70 million yuan credit line from Beijing Bank, using its property as collateral [34] - Bai Ao Intelligent signed a significant equipment sales contract worth approximately 27.5021 million yuan [35] Group 12 - ST Xinyan received all restructuring investment funds totaling 2.239 billion yuan, entering the execution phase of its restructuring plan [36] - Dalu Real Estate's subsidiary decided to terminate a planned acquisition of a 60% stake in Beijing Chengzhu Real Estate [38] - Huiyu Pharmaceutical's products received marketing approval in Italy and Norway [39]

每经AI快讯，12月19日，南网储能(600995.SH)公告称，公司重大资产重组配套募集资金投资项目南宁 抽水蓄能电站1号、2号机组于2025年12月19日投入考核试运行，3号、4号机组预计年底前投入考核试运 行，符合预期投产时间。机组将在完成考核试运行后正式投入商业运行。 ...

Core Viewpoint - Nanguang Energy (600995.SH) announced the significant asset restructuring and fundraising project for the Nanning Pumped Storage Power Station, with the first two units expected to enter trial operation by December 19, 2025, aligning with the projected commissioning timeline disclosed in the related report [1] Group 1 - The Nanning Pumped Storage Power Station has a total installed capacity of 4×300,000 kW [1] - Units 3 and 4 are expected to enter trial operation by the end of the year [1] - The units will officially commence commercial operation after completing the trial operation [1]

2025 年 12 月 19 日，南方电网储能股份有限公司（以下简称"公 司"）重大资产重组配套募集资金投资项目南宁抽水蓄能电站（装机 容量 4×30 万千瓦）1 号、2 号机组投入考核试运行，3 号、4 号机组 预计将于年底前投入考核试运行，符合公司《重大资产置换及发行股 份购买资产并募集配套资金暨关联交易报告书》披露的预期投产时间。 机组将在完成考核试运行后，正式投入商业运行。 特此公告。 南方电网储能股份有限公司董事会 2025 年 12 月 20 日 南方电网储能股份有限公司 关于募投项目南宁抽水蓄能电站投产的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者 重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 证券代码：600995 证券简称：南网储能 编号：2025-69 1 ...

格隆汇12月19日丨南网储能(600995.SH)公布,2025年12月19日，公司重大资产重组配套募集资金投资项 目南宁抽水蓄能电站（装机容量4×30万千瓦）1号、2号机组投入考核试运行，3号、4号机组预计将于 年底前投入考核试运行，符合公司《重大资产置换及发行股份购买资产并募集配套资金暨关联交易报告 书》披露的预期投产时间。机组将在完成考核试运行后，正式投入商业运行。 ...

南网私募基金管理有限公司 富 Ded A 8 国有全资 私募基金管理人 ll 0.0071% 南方财经12月16日电，天眼查App显示，12月16日，南网工融双碳（深圳）股权投资基金合伙企业（有限合伙）成立，执行事务合伙人为南网私募基金管理 有限公司、工银资本管理有限公司，出资额140亿人民币，经营范围为以私募基金从事股权投资、投资管理、资产管理等活动，由工银金融资产投资有限公 司、南网储能（600995）、广东电网有限责任公司等共同出资。 | | 皇公园 在用的 商业查询工具 | 童老板 童关系 音风险 | | | | --- | --- | --- | --- | --- | | | 南网工融双碳(深圳) 股权投资基金合伙企业(有限合 8 中小企业发展子基金旗下机构 | | 天眼一下 | 器 应用 ▼ 商务合作 : | | 基本信息 8 | 法律诉讼 | 经营风险 | 经营信息 公司发展 | 知 | | 工商信息 ● | | | | | | 工商信息 历史工商信息0 | | | | | | 企业名称 | 南网工融双碳(深圳) 股权投资基金合伙企业(有限合伙) | | | | | 执行事务合伙人 ② | 南 ...

| | 皇公司 音老板 都在用的商业查询工具 | 商关系 音风险 | | | | --- | --- | --- | --- | --- | | | 家中小企业发展子其全旗下机构 | 南网工融双碳(深圳)股权投资基金合伙企业(有限合 8 | 天眼一下 一周周五 | 商务合作 : | | 基本信息 8 | 法律诉讼 | 经营风险 | 经营信息 公司发展 | 知 | | 工商信息 ● | | | | | | 工商信息 历史丁商信息0 | | | | | | 企业名称 | 南网工融双碳(深圳) 股权投资基金合伙企业(有限合伙) | | | | | 执行事务合伙人 2 | 南网私募基金管理有限公司 日本 委派代表:张明明(来源于中墓 私草 协) | 登记状态 ② | 存续 | 天眼评分 2 | | | 工银资本管理有限公司 இ 委派代表:陆胜东(来源于中墓 协) | 成立日期 | 2025-12-16 | | | 统一社会信用代码 2 | 91440300MAK2GK154Q | 出资额 | 1400000万人民币 | 实缴资本 | | 工商注册号 | 440300227836160 | 纳税人识别号 ② | 914 ...

| 十百日 13日 全国企业信用查询 | 南网工融双碳（深圳）股权投资基金合伙企业 | | × 查一下 | | --- | --- | --- | --- | | 基本信息 13 | 法律诉讼 | 经营风险 | 经营信息 | | 执行事务合伙人 | 南网私募基金管理有限公司 | 登记状态 | 存续 | | | 工银资本管理有限公司 | 出资额 | 1400000万元 | | 组织机构代码 | MAK2GK15-4 | 工商注册号 | 440300227836160 | | 亚斯美霸 | 有限合伙 | 营业期限 | 2025-12-16 至 2039- | | 人员规模 | | 参保人数 | | | 所属地区 | 广东省深圳市福田区 | 登记机关 | 深圳市市场监督管理 | | 国标行业 | 资本市场服务 (J67) ∨ | 英文名 | Cspic Industrial Fina p (Limited Partnershi | | 主要经营场所 | 深圳市福田区莲花街道福中社区福中一路1001号生命保险大厦三十六层3605-13 | | | | 经营范围 | 一般经营项目是:无,许可经营项目是:以私募基金从事服 ...

企查查APP显示，近日，南网工融双碳（深圳）股权投资基金合伙企业（有限合伙）成立，出资额140 亿元，经营范围包含：以私募基金从事股权投资、投资管理、资产管理等活动。企查查股权穿透显示， 该企业由工银金融资产投资有限公司、南网储能等共同出资。 ...

证券日报网讯 12月9日，南网储能在互动平台回答投资者提问时表示，公司股东户数请参阅公司披露的 定期报告。 （文章来源：证券日报） ...